Novo Nordisk, AWS Sign AI Drug Discovery Deal, Establish London Hub

MT Newswires · 1d ago
09:02 AM EDT, 08/10/2026 (MT Newswires) -- Novo Nordisk (NOVO-B.CO) signed a partnership establishing Amazon's (AMZ.F) Amazon Web Services as its preferred cloud provider and strategic artificial intelligence partner to speed up drug discovery and modernize its operations. The Danish drugmaker said Monday the companies established a co-innovation hub in London, where AWS AI technologies and Novo Nordisk's data and insights are used to help cut the time to market future medicines.